Join to View Full Profile
1100 Walnut StMOB 5TH floorPhiladelphia, PA 19107
Phone+1 215-955-6750
Fax+1 215-923-8222
Are you Dr. Kennedy?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Eugene Kennedy, MD is a general surgeon in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania, Louisiana, and Maryland.
Education & Training
Johns Hopkins UniversityResidency, Surgery, 1996 - 2004
Virginia Commonwealth University School of MedicineClass of 1996
Certifications & Licensure
PA State Medical License 2005 - 2026
MD State Medical License 1999 - 2008
LA State Medical License 2005 - 2007
Publications & Presentations
PubMed
- 48 citationsInhibition of the BTK-IDO-mTOR axis promotes differentiation of monocyte-lineage dendritic cells and enhances anti-tumor T cell immunityMadhav D. Sharma, Rafal Pacholczyk, Huidong Shi, Zuzana Berrong, Yousef Zakharia
Immunity. 2021-10-12 - 57 citationsPhase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma.Yousef Zakharia, Robert R. McWilliams, Olivier Rixe, Joseph J. Drabick, Montaser Shaheen
Journal for Immunotherapy of Cancer. 2021-06-11 - 33 citationsEffect of Taxane Chemotherapy With or Without Indoximod in Metastatic Breast Cancer: A Randomized Clinical Trial.Veronica Mariotti, Hyo S. Han, Roohi Ismail-Khan, Shou-Ching Tang, Patrick M. Dillon
JAMA Oncology. 2021-01-01
Press Mentions
Summary of NewLink Genetics Corporation (NASDAQ:NLNK) Ratings as of Dec 17, 2018December 17th, 2018
Update Confirms Benefit of Pembrolizumab plus Indoximod in MelanomaSeptember 7th, 2017
